BCM
NARI

Bayesian Capital Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bayesian Capital Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,882
Closed -$1.58M – 1035
2024
Q4 		$1.58M Buy
+30,882
New +$1.52M 0.19% 157
2024
Q3 		– Sell
-21,122
Closed -$1.02M – 1096
2024
Q2 		$1.02M Buy
+21,122
New +$936K 0.12% 230
2023
Q4 		– Sell
-11,100
Closed -$726K – 1080
2023
Q3 		$726K Buy
+11,100
New +$698K 0.08% 276

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Bayesian Capital Management's NARI Position: Q1 2025 in Review

Bayesian Capital Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 30,882 shares — an estimated $1.58M sold.

Bayesian Capital Management first reported a position in NARI in Q3 2023 and held it in 3 quarters. The position peaked at $1.58M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Bayesian Capital Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 30,882 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $1.58M.
  • Bayesian Capital Management first reported a position in Inari Medical, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
  • Bayesian Capital Management's Inari Medical, Inc. Common Stock position peaked at $1.58M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.